Myrtelle

Wakefield, United States

Myrtelle is a gene therapy company that offers clinical trials for the treatment of rare monogenetic disorders.

$30.5M raised

Dec 2025

Series B

Top Investors

Panacea Venture

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Myrtelle raised?

Myrtelle has raised $30.5M in total funding. The most recent round was Series B. The last funding was announced in December 2025.

Who are Myrtelle's investors?

Myrtelle's investors include Panacea Venture.

Where is Myrtelle headquartered?

Myrtelle is headquartered in Wakefield, United States.

What does Myrtelle do?

Myrtelle is a gene therapy company that offers clinical trials for the treatment of rare monogenetic disorders.

What stage is Myrtelle at?

Myrtelle is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 23, 2025.

MLA

"Myrtelle — Funding & Investors." VCBacked, December 23, 2025, https://www.vcbacked.co/company/myrtelle. Accessed July 1, 2026.

APA

VCBacked. (2025). Myrtelle — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/myrtelle

Wikipedia (cite web)

{{cite web |title=Myrtelle — Funding & Investors |url=https://www.vcbacked.co/company/myrtelle |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 23, 2025.